Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis
Sponsor: Beijing Tongren Hospital
Summary
Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion, which may be accompanied by ocular symptoms, including eye itching, tearing, redness, and burning sensation, which are more common in patients with hay fever allergies. Bronchial asthma is associated with bronchial asthma in 40% of patients with AR, suggesting a comorbid feature of allergic disease.
Official title: The Efficacy and Safety of Humanized Antibody Targeting the Interleukin-4 Receptor Alpha Subunit (IL-4Rα) in Patients With Uncontrolled Seasonal Allergic Rhinitis Under Standard Treatment: A Randomized, Double-Blind, Placebo-controlled IIT Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-03-18
Completion Date
2026-06-30
Last Updated
2025-09-25
Healthy Volunteers
No
Conditions
Interventions
Interleukin-4 receptor responders
Interleukin-4 receptor was injected subcutaneously.
Placebo
Placebo was injected subcutaneously.
Locations (1)
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China